118 related articles for article (PubMed ID: 7496336)
21. Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema.
Funatsu H; Yamashita H; Sakata K; Noma H; Mimura T; Suzuki M; Eguchi S; Hori S
Ophthalmology; 2005 May; 112(5):806-16. PubMed ID: 15878060
[TBL] [Abstract][Full Text] [Related]
22. C-C chemokines in the vitreous of patients with proliferative vitreoretinopathy and proliferative diabetic retinopathy.
Capeans C; De Rojas MV; Lojo S; Salorio MS
Retina; 1998; 18(6):546-50. PubMed ID: 9869464
[TBL] [Abstract][Full Text] [Related]
23. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
[TBL] [Abstract][Full Text] [Related]
24. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
Wang X; Wang G; Wang Y
Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
[TBL] [Abstract][Full Text] [Related]
25. Vitreous leptin levels in retinal disease.
Maberley D; Cui JZ; Matsubara JA
Eye (Lond); 2006 Jul; 20(7):801-4. PubMed ID: 16052255
[TBL] [Abstract][Full Text] [Related]
26. Vitreous levels of interleukin-8 in patients with proliferative diabetic retinopathy.
Petrovic MG; Korosec P; Kosnik M; Hawlina M
Am J Ophthalmol; 2007 Jan; 143(1):175-6. PubMed ID: 17188064
[TBL] [Abstract][Full Text] [Related]
27. Multiplex bead analysis of vitreous humor of patients with vitreoretinal disorders.
Banerjee S; Savant V; Scott RA; Curnow SJ; Wallace GR; Murray PI
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2203-7. PubMed ID: 17460280
[TBL] [Abstract][Full Text] [Related]
28. Assessment of selected adhesion molecule and proinflammatory cytokine levels in the vitreous body of patients with type 2 diabetes--role of the inflammatory-immune process in the pathogenesis of proliferative diabetic retinopathy.
Adamiec-Mroczek J; Oficjalska-Młyńczak J
Graefes Arch Clin Exp Ophthalmol; 2008 Dec; 246(12):1665-70. PubMed ID: 18682976
[TBL] [Abstract][Full Text] [Related]
29. Inflammatory cytokines induce intercellular adhesion molecule-1 (ICAM-1) mRNA synthesis and protein secretion by human retinal pigment epithelial cell cultures.
Nagineni CN; Kutty RK; Detrick B; Hooks JJ
Cytokine; 1996 Aug; 8(8):622-30. PubMed ID: 8894437
[TBL] [Abstract][Full Text] [Related]
30. High vitreous concentration of IL-6 and IL-8, but not of adhesion molecules in relation to plasma concentrations in proliferative diabetic retinopathy.
Koskela UE; Kuusisto SM; Nissinen AE; Savolainen MJ; Liinamaa MJ
Ophthalmic Res; 2013; 49(2):108-14. PubMed ID: 23257933
[TBL] [Abstract][Full Text] [Related]
31. The significance of complement in proliferative vitreoretinopathy.
Grisanti S; Wiedemann P; Weller M; Heimann K; Zilles K
Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2711-7. PubMed ID: 1894471
[TBL] [Abstract][Full Text] [Related]
32. Intercellular adhesion molecule-1 (ICAM-1) and leukocyte function-associated antigen-1 (LFA-1) expression in human epiretinal membranes.
Heidenkummer HP; Kampik A
Graefes Arch Clin Exp Ophthalmol; 1992; 230(5):483-7. PubMed ID: 1355751
[TBL] [Abstract][Full Text] [Related]
33. Interleukin (IL)-6, interleukin (IL)-8 levels and cellular composition of the vitreous humor in proliferative diabetic retinopathy, proliferative vitreoretinopathy, and traumatic proliferative vitreoretinopathy.
Canataroglu H; Varinli I; Ozcan AA; Canataroglu A; Doran F; Varinli S
Ocul Immunol Inflamm; 2005; 13(5):375-81. PubMed ID: 16422002
[TBL] [Abstract][Full Text] [Related]
34. Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
Elner SG; Elner VM; Jaffe GJ; Stuart A; Kunkel SL; Strieter RM
Curr Eye Res; 1995 Nov; 14(11):1045-53. PubMed ID: 8585935
[TBL] [Abstract][Full Text] [Related]
35. [Idiopathic proliferative vitreoretinopathy. Activation of microglial cells as the deciding factor].
Weller M; Esser P; Heimann K; Wiedemann P
Ophthalmologe; 1992 Oct; 89(5):387-90. PubMed ID: 1304218
[TBL] [Abstract][Full Text] [Related]
36. Elevated Levels of Cytokines Associated with Th2 and Th17 Cells in Vitreous Fluid of Proliferative Diabetic Retinopathy Patients.
Takeuchi M; Sato T; Tanaka A; Muraoka T; Taguchi M; Sakurai Y; Karasawa Y; Ito M
PLoS One; 2015; 10(9):e0137358. PubMed ID: 26352837
[TBL] [Abstract][Full Text] [Related]
37. [A preliminary study on cytokines in proliferative vitreoretinopathy].
Li X; Huang J
Zhonghua Yan Ke Za Zhi; 1998 Jul; 34(4):256-9, 18. PubMed ID: 11877201
[TBL] [Abstract][Full Text] [Related]
38. Vitreous levels of reactive oxygen species in proliferative diabetic retinopathy.
Yeh PT; Yang CM; Huang JS; Chien CT; Yang CH; Chiang YH; Shih YF
Ophthalmology; 2008 Apr; 115(4):734-737.e1. PubMed ID: 18177940
[TBL] [Abstract][Full Text] [Related]
39. Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study.
Fosmark DS; Bragadóttir R; Stene-Johansen I; Berg JP; Berg TJ; Lund T; Sandvik L; Hanssen KF
Acta Ophthalmol Scand; 2007 Sep; 85(6):618-22. PubMed ID: 17488318
[TBL] [Abstract][Full Text] [Related]
40. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease.
Murugeswari P; Shukla D; Rajendran A; Kim R; Namperumalsamy P; Muthukkaruppan V
Retina; 2008 Jun; 28(6):817-24. PubMed ID: 18536597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
